
Pgiam/iStock via Getty Images
Phreesia (NYSE:PHR), a developer of patient intake management software, rose on Wednesday after Mizuho launched its coverage with an Outperform recommendation, citing potential in the company’s network solutions business.
The business, which provides patients with customized health content, generated $121.6M in revenue for